KRAS
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
KRAS
Oct 22, 2024, 08:02 |
Insight
Stephen V Liu: Jennifer A. Marks updates on KRAS, sotorasib and adagrasib
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…
Sep 2, 2024, 15:01 |
Insight
Liang Cheng: What’s the difference between urachal and nonurachal adenocarcinoma the bladder?
Liang Cheng shared on X: "What’s the difference between urachal and nonurachal adenocarcinoma the bladder?…
Aug 15, 2024, 15:06 |
Blog
Aaron Goodman: 2024 ELN AML risk treated with low intensity therapies
Aaron Goodman shared a post on X about a recent paper by Hartmut Döhner et al., commenting:…
Aug 11, 2024, 12:49 |
Insight
Anirban Maitra: Therapeutic targeting of Syndecan-1 axis in gastrointestinal cancers
Anirban Maitra shared on X: "New preprint by Wantong Yao, Haoqiang Ying, Scott Kopetz. Therapeutic…
Jul 12, 2024, 14:18 |
Blog
Updated review on targeting KRAS in NSCLC
Stephen V Liu shared on X: "Updated review on targeting KRAS in NSCLC available in…
Jul 12, 2024, 11:24 |
Insight
What comes after sotorasib and adagrasib?
Aakash Desai, Thoracic/Phase 1 Oncologist at UAB O'Neal Comprehensive Cancer Center, shared a post on…
Jul 10, 2024, 07:19 |
Insight
Tuomas Tammela: Co-targeting classical cells and KRAS augments response in pancreas cancer
Tuomas Tammela, Associate Member at Memorial Sloan Kettering Cancer Center, shared on X: "New Paper!…
Jul 5, 2024, 13:43 |
Insight
Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth
‘Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth.’ This paper was…
Jul 3, 2024, 03:34 |
Insight
Anirban Maitra: Gene on new preprint from Lowy Lab, UC San Diego Health Moores Cancer Center
Anirban Maitra shared on X: “New preprint from Lowy Lab, UC San Diego Health Moores…
Jun 29, 2024, 14:24 |
Societies
KRAS - the most commonly mutated oncogene in cancer
Amol Akhade shared on X: "KRAS - the most commonly mutated oncogene in cancer. Nice…
Jun 27, 2024, 14:49 |
Societies
ESMOGI24 Presentations Summarized By Megan Barnet
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 26, 2024, 12:40 |
Societies
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…
Jun 25, 2024, 07:47 |
Blog
Mark Lewis: It is UNACCEPTABLE to treat mCRC without knowing these biomarker
Mark Lewis shared a post by FDA Oncology on X, adding the following: . “We…
Jun 22, 2024, 14:35 |
Drugs
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
FDA Oncology shared on X: "FDA grants accelerated approval to adagrasib with cetuximab for KRAS…
Jun 13, 2024, 13:34 |
Insight
Stephen Liu: Report on brain metastases in patients with KRAS NSCLC
Stephen Liu shared on X/Twitter: "Report on brain metastases in patients with KRAS NSCLC in phase…
Jun 10, 2024, 09:53 |
Blog
We are proud to be members of Lung Cancer Europe - Oncogene Cancer Research
Oncogene Cancer Research recently shared a post by Lung Cancer Europe on LinkedIn, adding: "We…
May 25, 2024, 14:48 |
Blog
Susanna Greer: Lung Cancer Knocked on the Wrong Door
Susanna Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the following…
May 18, 2024, 09:18 |
Blog
Vivek Subbiah: KRAS inhibition reminds me of this Greek restaurant KRASi in Boston
Vivek Subbiah shared a post on X/Twitter: ''Pleased to share our editorial in an ASCO journal.…
May 16, 2024, 11:47 |
Insight
Aakash Desai: We explored the molecular characteristics of KRAS wildtype PDAC
Aakash Desai, Assistant Professor at O'Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: "In…
May 16, 2024, 09:09 |
Blog
Kohei Shitara: Happy to report biomarkers in DESTINIY GC01 at Nature Medicine
Kohei Shitara, Medical oncologist at National Cancer Center Hospital East, Japan shared a post on X:…
May 15, 2024, 11:55 |
Blog
Vivek Subbiah: Our editorial on the Mission to Target KRAS in Colorectal Cancer
Vivek Subbiah shared a post on LinkedIn: "Delighted to share our editorial - just published in…
May 8, 2024, 18:00 |
Blog
Susanna F. Greer: Pancreatic ductal adenocarcinoma - The party crasher
Susanna F. Greer, Chief Scientific Officer at the V Foundation, published the following newsletter on LinkedIn:…
May 8, 2024, 00:58 |
Blog
Stephen V Liu: Dr. Passiglia Fra at Rome Lung 24 illustrates the limited role of immunotherapy in driver positive NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
Apr 29, 2024, 08:17 |
Insight
Bob Li: It was a privilege to lead the first international clinical trial to crack KRAS
Bob Li, Chief Scientific Officer of MSK Direct at Memorial Sloan Kettering Cancer Center, shared…
Apr 28, 2024, 16:38 |
Blog
Hidehito Horinouchi: Abstract Titles Clinical Science Symposium: Targeting KRAS in NSCLC
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, shared a…
Apr 21, 2024, 21:21 |
Insight
Mainak Bardhan: Miami Cancer Institute Research Precision Oncology symposium 2nd Annual at The Ritz Carlton spearhead by one and only Manmeet Ahluwalia
Mainak Bardhan, Chief Scientific Officer, Chief of Medical Oncology and Deputy Director of Miami Cancer Institute,…
Apr 14, 2024, 12:08 |
Blog
Vivek Subbiah: Talk about shaking the field of cancer research- cracking KRAS
Vivek Subbiah shared a post on LinkedIn: ''Talk about shaking the field of cancer research- cracking…
Mar 4, 2024, 17:40 |
Insight
Humam Kadara: An atlas of normal and cancerous epithelial cells in lung adenocarcinoma
Humam Kadara, Professor of Translational Molecular Pathology at The University of Texas MD Anderson Cancer…
Jan 26, 2024, 17:17 |
Societies
30 Posts Not To Miss From ASCO GI24
The ASCO Gastrointestinal Cancer Symposium (GI24) took place from the 18th to the 20th of…
All:
29
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube